See more : VIP ComLink, Inc. (VIPK) Income Statement Analysis – Financial Results
Complete financial analysis of Prenetics Global Limited (PRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Prenetics Global Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Oswal Greentech Limited (BINDALAGRO.NS) Income Statement Analysis – Financial Results
- Apex International Co., Ltd. (4927.TW) Income Statement Analysis – Financial Results
- Covestro AG (1COV.F) Income Statement Analysis – Financial Results
- Convergenze S.p.A. Società Benefit (CVG.MI) Income Statement Analysis – Financial Results
- Morito Co., Ltd. (9837.T) Income Statement Analysis – Financial Results
Prenetics Global Limited (PRE)
About Prenetics Global Limited
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 21.74M | 275.76M | 275.85M | 65.18M | 9.23M |
| Cost of Revenue | 12.91M | 144.21M | 169.72M | 38.83M | 6.52M |
| Gross Profit | 8.83M | 131.55M | 106.13M | 26.34M | 2.72M |
| Gross Profit Ratio | 40.61% | 47.71% | 38.47% | 40.42% | 29.41% |
| Research & Development | 11.66M | 15.52M | 10.56M | 2.78M | 2.99M |
| General & Administrative | 41.44M | 96.06M | 83.99M | 16.62M | 13.19M |
| Selling & Marketing | 8.24M | 13.30M | 21.93M | 6.49M | 4.77M |
| SG&A | 49.68M | 109.36M | 105.92M | 23.11M | 17.96M |
| Other Expenses | -606.84K | -149.23M | -7.93K | -513.86K | 40.15K |
| Operating Expenses | 60.74M | 124.88M | 116.48M | 25.38M | 20.94M |
| Cost & Expenses | 73.65M | 269.09M | 286.20M | 64.21M | 27.46M |
| Interest Income | 3.92M | 472.19K | 3.98K | 8.04K | 15.51K |
| Interest Expense | 119.66K | 3.99M | 228.18K | 59.57K | 69.39K |
| Depreciation & Amortization | 7.79M | 7.54M | 7.35M | 2.43M | 2.23M |
| EBITDA | -47.90M | -214.28M | -157.70M | -1.42M | -18.57M |
| EBITDA Ratio | -220.29% | 15.67% | -58.89% | -0.87% | -200.54% |
| Operating Income | -51.91M | 207.42M | -10.35M | 967.46K | -18.23M |
| Operating Income Ratio | -238.73% | 75.22% | -3.75% | 1.48% | -197.44% |
| Total Other Income/Expenses | -4.76M | -159.80M | -159.89M | -2.91M | -69.39K |
| Income Before Tax | -56.67M | -183.31M | -170.28M | -3.90M | -20.87M |
| Income Before Tax Ratio | -260.64% | -66.47% | -61.73% | -5.99% | -226.06% |
| Income Tax Expense | -269.36K | 7.15M | 3.73M | -1.94M | -677.47K |
| Net Income | -62.72M | -190.45M | -174.02M | -1.96M | -20.20M |
| Net Income Ratio | -288.48% | -69.06% | -63.08% | -3.01% | -218.73% |
| EPS | -5.58 | -37.57 | -14.77 | -0.27 | -2.73 |
| EPS Diluted | -5.58 | -37.57 | -14.77 | -0.27 | -2.73 |
| Weighted Avg Shares Out | 11.25M | 5.07M | 11.78M | 7.40M | 7.40M |
| Weighted Avg Shares Out (Dil) | 11.25M | 5.07M | 11.78M | 7.40M | 7.40M |
Prenetics Global Limited (PRE) Flat As Market Gains: What You Should Know
Prenetics Global Limited (PRE) closed the most recent trading day at $0.89, making no change from the previous trading session.
Prenetics Global Limited (PRE) Loses -24.21% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Prenetics Global Limited (PRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Can Penny Stocks Make You Money Right Now?
Can you make money trading penny stocks in 2023? The post Can Penny Stocks Make You Money Right Now?
Why Prenetics Global Stock Is Skyrocketing Today
The company announced a key FDA clearance.
PartnerRe to Release 2015 Fourth Quarter and Full Year Results and Host Analyst Conference Call and Webcast
PEMBROKE, Bermuda--(BUSINESS WIRE)--PartnerRe Ltd. (NYSE:PRE) today announced dates for its 2015 fourth quarter and full year results press release and conference call. PartnerRe will release its 2015 fourth quarter and full year results after the market close on Monday, February...
PartnerRe to Release 2015 Third Quarter and Nine Month Results and Host Analyst Conference Call and Webcast
PEMBROKE, Bermuda--(BUSINESS WIRE)--PartnerRe Ltd. (NYSE:PRE) today announced dates for its 2015 third quarter and nine month results press release and conference call. PartnerRe will release its 2015 third quarter and nine month results after the market close on Monday, October...
PartnerRe to Release 2015 Second Quarter and Half Year Results and Host Analyst Conference Call and Webcast
PEMBROKE, Bermuda--(BUSINESS WIRE)--PartnerRe Ltd. (NYSE:PRE) today announced dates for its 2015 second quarter and half year results press release and conference call. PartnerRe will release its 2015 second quarter and half year results after the market close on Monday, July...
PartnerRe Reaffirms Its Commitment to the Merger with AXIS Capital
PEMBROKE, Bermuda--(BUSINESS WIRE)--PartnerRe Ltd. (NYSE:PRE) today announced that its Board of Directors has rejected the unsolicited proposal by EXOR S.p.A. to acquire PartnerRe at a price of $130 per share. The Company further reaffirmed its commitment to the planned merger...
PartnerRe to Release 2015 First Quarter Results and Host Analyst Conference Call and Webcast
PEMBROKE, Bermuda--(BUSINESS WIRE)--PartnerRe Ltd. (NYSE:PRE) today announced dates for its 2015 first quarter results press release and conference call. PartnerRe will release its 2015 first quarter results after the market close on Monday, April 27, 2015. PartnerRe senior management will...
AXIS Capital and PartnerRe to Combine in $11 Billion Merger
PEMBROKE, Bermuda--(BUSINESS WIRE)--AXIS Capital Holdings Limited (“AXIS Capital”) (NYSE:AXS) and PartnerRe Ltd. (NYSE:PRE) today announced that they have signed a definitive amalgamation agreement to create one of the world’s preeminent specialty insurance and reinsurance companies, with gross premiums written in...
Source: https://incomestatements.info
Category: Stock Reports